Global Disease Risk and Health Genetic Test Market Growth (Status and Outlook) 2019-2024
Table of Contents
2019-2024 Global Disease Risk and Health Genetic Test Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Disease Risk and Health Genetic Test Market Size 2014-2024
- 2.1.2 Disease Risk and Health Genetic Test Market Size CAGR by Region
- 2.2 Disease Risk and Health Genetic Test Segment by Type
- 2.2.1 Celiac Disease
- 2.2.2 Parkinson Disease
- 2.2.3 Alzheimer Disease
- 2.2.4 Other
- 2.3 Disease Risk and Health Genetic Test Market Size by Type
- 2.3.1 Global Disease Risk and Health Genetic Test Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Disease Risk and Health Genetic Test Market Size Growth Rate by Type (2014-2019)
- 2.4 Disease Risk and Health Genetic Test Segment by Application
- 2.4.1 Online
- 2.4.2 Offline
- 2.5 Disease Risk and Health Genetic Test Market Size by Application
- 2.5.1 Global Disease Risk and Health Genetic Test Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Disease Risk and Health Genetic Test Market Size Growth Rate by Application (2014-2019)
3 Global Disease Risk and Health Genetic Test by Players
- 3.1 Global Disease Risk and Health Genetic Test Market Size Market Share by Players
- 3.1.1 Global Disease Risk and Health Genetic Test Market Size by Players (2017-2019)
- 3.1.2 Global Disease Risk and Health Genetic Test Market Size Market Share by Players (2017-2019)
- 3.2 Global Disease Risk and Health Genetic Test Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Disease Risk and Health Genetic Test by Regions
- 4.1 Disease Risk and Health Genetic Test Market Size by Regions
- 4.2 Americas Disease Risk and Health Genetic Test Market Size Growth
- 4.3 APAC Disease Risk and Health Genetic Test Market Size Growth
- 4.4 Europe Disease Risk and Health Genetic Test Market Size Growth
- 4.5 Middle East & Africa Disease Risk and Health Genetic Test Market Size Growth
5 Americas
- 5.1 Americas Disease Risk and Health Genetic Test Market Size by Countries
- 5.2 Americas Disease Risk and Health Genetic Test Market Size by Type
- 5.3 Americas Disease Risk and Health Genetic Test Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Disease Risk and Health Genetic Test Market Size by Countries
- 6.2 APAC Disease Risk and Health Genetic Test Market Size by Type
- 6.3 APAC Disease Risk and Health Genetic Test Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Disease Risk and Health Genetic Test by Countries
- 7.2 Europe Disease Risk and Health Genetic Test Market Size by Type
- 7.3 Europe Disease Risk and Health Genetic Test Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Disease Risk and Health Genetic Test by Countries
- 8.2 Middle East & Africa Disease Risk and Health Genetic Test Market Size by Type
- 8.3 Middle East & Africa Disease Risk and Health Genetic Test Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Disease Risk and Health Genetic Test Market Forecast
- 10.1 Global Disease Risk and Health Genetic Test Market Size Forecast (2019-2024)
- 10.2 Global Disease Risk and Health Genetic Test Forecast by Regions
- 10.2.1 Global Disease Risk and Health Genetic Test Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Disease Risk and Health Genetic Test Forecast by Type
- 10.8 Global Disease Risk and Health Genetic Test Forecast by Application
11 Key Players Analysis
- 11.1 23andMe
- 11.1.1 Company Details
- 11.1.2 Disease Risk and Health Genetic Test Product Offered
- 11.1.3 23andMe Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 23andMe News
- 11.2 MyHeritage
- 11.2.1 Company Details
- 11.2.2 Disease Risk and Health Genetic Test Product Offered
- 11.2.3 MyHeritage Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 MyHeritage News
- 11.3 LabCorp
- 11.3.1 Company Details
- 11.3.2 Disease Risk and Health Genetic Test Product Offered
- 11.3.3 LabCorp Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 LabCorp News
- 11.4 Myriad Genetics
- 11.4.1 Company Details
- 11.4.2 Disease Risk and Health Genetic Test Product Offered
- 11.4.3 Myriad Genetics Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Myriad Genetics News
- 11.5 Ancestry.com
- 11.5.1 Company Details
- 11.5.2 Disease Risk and Health Genetic Test Product Offered
- 11.5.3 Ancestry.com Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Ancestry.com News
- 11.6 Quest Diagnostics
- 11.6.1 Company Details
- 11.6.2 Disease Risk and Health Genetic Test Product Offered
- 11.6.3 Quest Diagnostics Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Quest Diagnostics News
- 11.7 Gene By Gene
- 11.7.1 Company Details
- 11.7.2 Disease Risk and Health Genetic Test Product Offered
- 11.7.3 Gene By Gene Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Gene By Gene News
- 11.8 DNA Diagnostics Center
- 11.8.1 Company Details
- 11.8.2 Disease Risk and Health Genetic Test Product Offered
- 11.8.3 DNA Diagnostics Center Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 DNA Diagnostics Center News
- 11.9 Invitae
- 11.9.1 Company Details
- 11.9.2 Disease Risk and Health Genetic Test Product Offered
- 11.9.3 Invitae Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Invitae News
- 11.10 IntelliGenetics
- 11.10.1 Company Details
- 11.10.2 Disease Risk and Health Genetic Test Product Offered
- 11.10.3 IntelliGenetics Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 IntelliGenetics News
- 11.11 Ambry Genetics
- 11.12 Living DNA
- 11.13 EasyDNA
- 11.14 Pathway Genomics
- 11.15 Centrillion Technology
- 11.16 Xcode
- 11.17 Color Genomics
- 11.18 Anglia DNA Services
- 11.19 African Ancestry
- 11.20 Canadian DNA Services
- 11.21 DNA Family Check
- 11.22 Alpha Biolaboratories
- 11.23 Test Me DNA
- 11.24 23 Mofang
- 11.25 Genetic Health
- 11.26 DNA Services of America
- 11.27 Shuwen Health Sciences
- 11.28 Mapmygenome
- 11.29 Full Genomes
12 Research Findings and Conclusion
The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder.
According to this study, over the next five years the Disease Risk and Health Genetic Test market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Disease Risk and Health Genetic Test business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Disease Risk and Health Genetic Test market by product type, application, key companies and key regions.
This study considers the Disease Risk and Health Genetic Test value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Celiac Disease
Parkinson Disease
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Online
Offline
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Disease Risk and Health Genetic Test market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Disease Risk and Health Genetic Test market by identifying its various subsegments.
Focuses on the key global Disease Risk and Health Genetic Test players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Disease Risk and Health Genetic Test with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Disease Risk and Health Genetic Test submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.